Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study-Reference-Cited by-同舟云学术

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study

Published:2021-11-04 Issue:1 Volume:61 Page:52-57
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Schmidinger Manuela¹,Motzer Robert J.²,Rolland Frederic³,Staehler Michael⁴,Rink Michael⁵,Retz Margitta⁶,Csoszi Tibor⁷,McCaffrey John A.⁸,De Giorgi Ugo⁹,Caserta Claudia¹⁰,Duran Ignacio¹¹,Benzaghou Fawzi¹²,Clary Douglas O.¹³,Albiges Laurence¹⁴,Choueiri Toni K.¹⁵,Tannir Nizar M.¹⁶

Affiliation:

1. Department of Urology, Medical University of Vienna, Vienna, Austria

2. Memorial Sloan Kettering Cancer Center, New York, NY, USA

3. Institut de Cancérologie de l’Ouest, Saint-Herblain, France

4. Department of Urology, Ludwig-Maximilians-Universität München, Munich, Germany

5. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

6. Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany

7. Jász-Nagykun-Szolnok County Hospital, Szolnok, Hungary

8. Cancer Trials Ireland, Dublin, Ireland

9. IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy

10. Medical and Translational Oncology Unit, Azienda Ospedaliera Santa Maria, Terni, Italy

11. Medical Oncology Department, Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Spain

12. Ipsen Bioscience, Oncology R&D, Cambridge, MA, USA

13. Exelixis Inc., Alameda, CA, USA

14. Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France

15. Dana-Farber Cancer Institute, Boston, MA, USA

16. MD Anderson Cancer Center Hospital, The University of Texas, Houston, TX, USA

Funder

Ipsen

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1995041

Reference24 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Renal cell carcinoma

4. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

5. Update on the biology and management of renal cell carcinoma